Wellington Management Group LLP Has $230.74 Million Position in Heartflow, Inc. $HTFL

Wellington Management Group LLP cut its position in Heartflow, Inc. (NASDAQ:HTFL) by 34.4% during the 2nd quarter, HoldingsChannel reports. The firm owned 7,864,226 shares of the company’s stock after selling 4,118,057 shares during the quarter. Wellington Management Group LLP owned about 0.09% of Heartflow worth $230,736,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. XXEC Inc. acquired a new position in shares of Heartflow in the 2nd quarter valued at $2,524,764,000. BlackRock Inc. acquired a new stake in Heartflow during the 2nd quarter worth $152,502,000. Bamco Inc. NY bought a new position in Heartflow during the second quarter worth about $94,625,000. Jupiter Topco LLC bought a new position in Heartflow during the second quarter worth about $70,983,000. Finally, Janus Henderson Group PLC grew its stake in Heartflow by 152.0% in the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after acquiring an additional 1,315,416 shares during the period.

Heartflow Stock Performance

HTFL stock opened at $47.78 on Monday. The stock has a 50-day moving average price of $32.25 and a two-hundred day moving average price of $29.06. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $51.19. The stock has a market cap of $4.15 billion and a PE ratio of -26.11.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. The company had revenue of $64.08 million for the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business’s revenue for the quarter was up 47.7% compared to the same quarter last year. On average, analysts forecast that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Campbell Rogers sold 9,219 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $41.23, for a total transaction of $380,099.37. Following the completion of the transaction, the insider directly owned 86,459 shares of the company’s stock, valued at $3,564,704.57. This trade represents a 9.64% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 27,230 shares of Heartflow stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $50.00, for a total transaction of $1,361,500.00. Following the completion of the sale, the chief executive officer owned 360,814 shares in the company, valued at $18,040,700. This trade represents a 7.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 191,271 shares of company stock worth $7,089,136. 7.70% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research firms have recently commented on HTFL. Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. JPMorgan Chase & Co. boosted their price objective on Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Morgan Stanley increased their target price on Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research note on Friday, August 14th. Piper Sandler restated an “overweight” rating and set a $45.00 target price (up from $38.00) on shares of Heartflow in a report on Friday, August 14th. Finally, Canaccord Genuity Group upped their price target on shares of Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Heartflow currently has a consensus rating of “Moderate Buy” and an average price target of $43.43.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.